News

We are pleased to announce that fungalAi is now part of an Australian multi-centre clinical trial targeting difficult to diagnose fungal pneumonia. This trial involves 7 health networks around the country including children with details available at Clintrials.gov (NCT 03793231 "Innovative use of fungalAi for anti fungal stewardship in haematology patients"). This validation study is challenging , exciting and vital to vulnerable patient health.

We thank the funding organisations who have made this milestone possible: The Alfred Foundation, Monash University, Monash Institute of Medical Engineering and the Medical Research Future Fund of Australia.